IL32 and atherosclerosis: We demonstrated that specific exogenous IL-32 isoforms (IL-32β and γ) have the potential to impact coronary artery endothelial cells leading to their dysfunction and recruitment of monocytes, two conditions linked with the development of atherosclerosis [45,46].